Atherosclerosis is the underlying cause of many cardiovascular diseases and remains a major contributor to global morbidity and mortality. This track focuses on the biological mechanisms, risk factors, and clinical implications of atherosclerotic disease and lipid abnormalities.
Sessions will examine cholesterol metabolism, lipid management strategies, inflammation, plaque development, and the role of genetics in cardiovascular risk. Experts will discuss current treatment guidelines, novel lipid-lowering therapies, and preventive approaches for reducing disease progression.
Participants will gain a deeper understanding of the relationship between lipid disorders and cardiovascular health. The track aims to promote evidence-based practices that support early intervention, risk reduction, and improved long-term cardiovascular outcomes.